Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials

UCLA's Jonsson Comprehensive Cancer Center

UCLA's Jonsson Comprehensive Cancer Center
JCCC: A Comprehensive Cancer Center
JCCC Member Directory
Calendar
Contact Us
Map and Directions to JCCC
Privacy Practices
 
About Us

JCCC Member Directory

Mark S. Litwin, M.D.
Mark S. Litwin, M.D.

Specialty:

Urology

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Professor, Department of Health Services, Department of Urology
Member, JCCC Patients and Survivors Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
Public Health/Public Policy, UCLA School of Public Health, 1991 - 1993
Residency:
Urology, Brigham and Women's Hospital, 1987 - 1991
Internship:
Surgery, Brigham and Women's Hospital, 1985 - 1987
Medical Degree:
M.D., Emory University School of Medicine, 1985

Certification(s):

Medical Board Certification(s):
Urology, American Board of Urology, 1995

Contact Information:

Urology:
(310) 794-7700 Information and referral
(310) 206-8183 Department office
Genitourinary Oncology:
(310) 794-7700 Information and referral
Adult and General Urology:
(310) 794-7700 Information and referral
Prostate Research and Treatment Program:
(310) 794-6374 Information and referral
(310) 794-7700 Referring physician
E-mail:
mlitwin@mednet.ucla.edu

Practice Information:

Clinical Interest(s):
Circumcision Adult
Circumcision <1Mo and <10Lbs
Hematuria
Kidney Cancer
Masses
Nerve Sparing Prostatectomy
Oncology
Penile Cancer
Prostate Cancer
Prostate Nodules
Testicular Cancer
Urinary Diversion
Vasectomy

Scientific Interest(s):

Dr. Mark S. Litwin devotes his time to surgical care and research for patients with urologic cancers. His research activity focuses on quality of care and medical outcomes assessment, health-related quality of life, medical decision-making and prostate cancer in the underserved. He has published numerous quality-of-care and quality-of-life measures (including the UCLA Prostate Cancer Index) for use in men with prostate cancer. He has also published extensively on quality of care in patients with bladder and kidney cancer. His research has been continuously R-01 funded by the National Institutes of Health since 1997. He has also received grants from the American Cancer Society, Department of Defense, California Department of Public Health, and other organizations.

Litwin directs IMPACT (www.california-impact.org), a $73-million program for low-income, uninsured Californians with prostate cancer. He is also the principal investigator of Urologic Diseases in America (www.udaonline.net), a $14-million NIH project quantifying the burden of urologic diseases on the American public. His former fellows serve in academic positions throughout the world.

Selected Cancer-Related Publications:

Zavala MW, Maliski SL, Kwan L, Miller DC, Fink A, Litwin MS. Longitudinal quality of life in low-income men in a state-funded prostate cancer treatment program. J Health Care Poor Underserved. 2008 Feb;19(1):200-14.

Miller DC, Saigal CS, Banerjee M, Hanley J, Litwin MS; Urologic Diseases in America Project. Diffusion of surgical innovation among patients with kidney cancer. Cancer. 2008 Apr 15;112(8):1708-17.

Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007; 109(11): 2239-47.

Miller DC, Spencer BA, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT, Litwin MS. Treatment choice and quality of care for men with localized prostate cancer. Med Care. 2007; 45(5): 401-9.

Litwin MS, Miller DC. Treating older men with prostate cancer: survival (or selection) of the fittest? JAMA. 2006; 296(22): 2733-4.

In the News: